PTC Therapeutics shares are trading lower after the CHMP issued a negative opinion on Translarna following the European Commission's request for review.
PTC Therapeutics, Inc. -0.66% Pre
PTC Therapeutics, Inc. PTCT | 40.48 40.48 | -0.66% 0.00% Pre |
PTC Therapeutics shares are trading lower after the CHMP issued a negative opinion on Translarna following the European Commission's request for review.